Insiders · Profile

TAPARO ANTHONY

Chief Growth Officer at Surgery Partners. Filing since 10 May 2021. CIK 0001735245

Company
Date
Role
Action
Shares
Amount
Of holding
12 Mar 2024
Chief Growth Officer
Sold at will
787
$23.51K
0.8%
11 Mar 2024
Chief Growth Officer
Sold at will
651
$19.23K
0.6%
5 Mar 2024
Chief Growth Officer
Sold at will
1,347
$41.35K
1.3%
13 Feb 2024
Chief Growth Officer
Sold at will
1,100
$36.74K
1.2%
15 Mar 2023
Chief Growth Officer
Sold, plan not stated
32
$963.20
0.0%
14 Mar 2023
Chief Growth Officer
Sold, plan not stated
4,067
$126.52K
4.1%
13 Mar 2023
Chief Growth Officer
Sold, plan not stated
1,509
$45.41K
1.5%
27 Feb 2023
Chief Growth Officer
Sold, plan not stated
6,582
$220.63K
6.7%
13 Feb 2023
Chief Growth Officer
Sold, plan not stated
1,085
$36.79K
1.1%
24 Mar 2022
Chief Growth Officer
Sold, plan not stated
5,000
$267.50K
4.8%
16 Mar 2022
Chief Growth Officer
Sold, plan not stated
1,698
$86.39K
1.6%
15 Mar 2022
Chief Growth Officer
Sold, plan not stated
7,426
$366.10K
6.6%
11 Mar 2022
Chief Growth Officer
Sold, plan not stated
660
$36.30K
0.6%
28 Feb 2022
Chief Growth Officer
Sold, plan not stated
5,653
$295.54K
5.2%
10 May 2021
Chief Growth Officer
Sold, plan not stated
63,588
$3.21M
36.9%
15 decisions on file.